Literature DB >> 3827338

Acquired sideroblastic anaemia after aplastic anaemia caused by D-penicillamine therapy for rheumatoid arthritis.

A C Ramselaar, A W Dekker, O Huber-Bruning, J W Bijlsma.   

Abstract

A 68 year old man with rheumatoid arthritis developed marrow aplasia during D-penicillamine treatment. Recovery of granulopoiesis and erythropoiesis was ineffective with features of a secondary sideroblastic anaemia. Absence of megakaryopoiesis persisted. Therapeutic measures failed, and the patient finally died. These events illustrate a haematopoietic stem cell injury induced by D-penicillamine.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3827338      PMCID: PMC1002083          DOI: 10.1136/ard.46.2.156

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  1 in total

1.  Acquired sideroblastic anaemia associated with penicillamine therapy for rheumatoid arthritis.

Authors:  L Kandola; A J Swannell; A Hunter
Journal:  Ann Rheum Dis       Date:  1995-06       Impact factor: 19.103

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.